Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001116679-06-002118
Filing Date
2006-09-11
Accepted
2006-09-11 12:42:16
Documents
8
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 JUNE 30, 2006 bio10k.txt 10-K 334361
2 EX. 23.1: CONSENT OF J.H. COHN LLP ex23-1.txt EX-23 1000
3 EX. 23.2: CONSENT OF DELOITTE & TOUCHE LLP ex23-2.txt EX-23 801
4 EX. 23.3: CONSENT OF GRANT THORNTON LLP ex23-3.txt EX-23 916
5 EX. 31.1: 302 CERT OF CEO ex31-1.txt EX-31 4060
6 EX. 31.2: 302 CERT OF CFO ex31-2.txt EX-31 4106
7 EX. 32.1: 906 CERT OF CEO ex32-1.txt EX-32 1415
8 EX.. 32.2: 906 CERT OF CFO ex32-2.txt EX-32 1403
  Complete submission text file 0001116679-06-002118.txt   349607
Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Filer) CIK: 0001028205 (see all company filings)

EIN.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-31787 | Film No.: 061083559
SIC: 2834 Pharmaceutical Preparations